# FDA Inspection 1293334 - Tissue Bank Manitoba - September 04, 2025

Source: https://www.keypedia.com/records/fda_inspections/tissue-bank-manitoba/8f47567d-322a-4fff-8e76-1b53fc3a4e26
Source feed: FDA_Inspections

> FDA Inspection 1293334 for Tissue Bank Manitoba on September 04, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293334
- Company Name: Tissue Bank Manitoba
- Inspection Date: 2025-09-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1293334 - 2025-09-04](https://www.keypedia.com/records/fda_inspections/tissue-bank-manitoba/230cea8c-ca01-4f2e-84da-01547340c343)
- [FDA Inspection 674511 - 2010-07-07](https://www.keypedia.com/records/fda_inspections/tissue-bank-manitoba/a4dd3dc0-a949-4045-8aaf-3fb4bf44f0fe)

Company: https://www.keypedia.com/companies/tissue-bank-manitoba/256f0696-9a96-4cf9-adef-b5ab6d576bd8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d